Many best practices for reviewing and approval information can facilitate compliance with CFR Part 11’s electronic signature guidelines. This includes features like:
Controlled Workflow
When a user wants to make a change to a controlled document
or submit it for review in Meridian Cloud, they initiate a controlled workflow
to make that change. This forces documents to move through a defined workflow
that requires users to pass through pre-defined review and approval steps. This
helps maintain compliance and ensure that all boxes are checked.
Electronic Signatures
In Meridian Cloud for Life Sciences, electronic
signatures are required when a GMP document is put into a workflow. Each person
that must provide their electronic signature will receive an email letting them
know that there is a document ready for their review. As each user reviews or
approves the document, their electronic signature is manifested on the PDF
rendition of the document in the order they signed. This not only helps ensure
that the right people see the document but also simplifies document management
and streamlines the audit trail.
Electronic Print Stamp
Every time you view, modify or print a GMP document in
Meridian Cloud for Life Sciences, a print stamp and watermark will be
automatically generated by the system on each PDF rendering of the document to
provide key timing information. This can help maintain consistency of work
across time zones and help employees understand, at a glance, which document is
the latest and most up-to-date version.
7. Choose The Right QMS Solution
Compliance is a complex, ongoing process – and getting it
right will be much easier with the right tools in place. When it comes to your
QMS software, this should be a tool -- like Meridian Cloud for Life Sciences –
that is pre-validated and fully aligned with CFR part 11.
Food and Drug Administration CFR Title 21 Part 11
FDA CFR Title 21 overview
The Code of Federal Regulations (CFR) contains the rules and
regulations for executive departments and agencies of the US federal
government. Each of the 50 titles of the 21 cfr part 11 electronic signature addresses a different regulated
area.
FDA CFR Title 21 regulates food and drugs manufactured or consumed in the United States, under the jurisdiction of the Food and Drug Administration (FDA), the Drug Enforcement Administration, and the Office of National Drug Control Policy. The regulations outlined in CFR Title 21 Part 11 set the ground rules for the technology systems that manage information used by organizations subject to FDA oversight. Any technology system that governs such GxP processes as Good Laboratory Practices (GLP), Good Clinical Practices (GCP), and Good Manufacturing Practices (GMP) also requires validation of its adherence to GxP.
CFR Title 21 Part 11 sets requirements to ensure that
electronic records and signatures are trustworthy, reliable, and equivalent
substitutes for paper records and handwritten signatures. It also offers
guidelines to improve the security of computer systems in FDA-regulated
industries. Subject companies must prove that their processes and products work
as they are designed to, and if these process and products change, they must
revalidate that proof. The best practices guidelines cover:
Standard operating procedures and controls that support
electronic records and signatures such as data backup, security, and computer
system validation.
Features that ensure that the computer system is secure,
contains audit trails for data values, and ensures the integrity of electronic
signatures.
Validation and documentation that supply evidence that the
system does what is intended, and that users can detect when the system is not
working as designed.
Microsoft and FDA CFR Title 21
Microsoft enterprise cloud services undergo regular
independent third-party SOC 1 Type 2 and SOC 2 Type 2 audits and are certified
according to ISO/IEC 27001 and ISO/IEC 27018 standards.
Although these regular audits and certifications do not
specifically focus on FDA regulatory compliance, their purpose and objectives
are similar in nature to those of CFR Title 21 Part 11, and serve to help
ensure the confidentiality, integrity, and availability of data stored in
Microsoft cloud services. Our qualification approach is also based on industry
best practices, including the International Society for Pharmaceutical
Engineering (ISPE) GAMP series of Good Practices Guides and the Pharmaceutical
Inspection Cooperation Scheme (PIC/S) Good Practices for Computerized Systems
in Regulated GxP Environments.
Customers can request access to the compliance reports,
subject to nondisclosure agreement terms and conditions, through their
Microsoft account representative, or through the Service Trust Portal. In
addition, qualification guidelines for Microsoft Azure and Microsoft Office 365
provide a detailed explanation of how Microsoft audit controls correspond to
the requirements of CFR Title 21 Part 11, guidance for implementing an FDA
qualification strategy, and a description of areas of shared responsibility.
Comments
Post a Comment